MENLO PARK, Calif.--(BUSINESS WIRE)--Depomed, Inc. (NASDAQ:DEPO) announced today that David B. Zenoff has been appointed to the company’s board of directors. Dr. Zenoff brings to Depomed over 30 years of experience consulting on corporate strategy and organizational development for both small and large multinational companies.
